Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Metlife (MET-PA) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Metlife (MET-PA) over the last 17 years, with Q3 2025 value amounting to 35.07%.

  • Metlife's EBIT Margin rose 67300.0% to 35.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.64%, marking a year-over-year increase of 8800.0%. This contributed to the annual value of 29.97% for FY2024, which is 2100.0% up from last year.
  • According to the latest figures from Q3 2025, Metlife's EBIT Margin is 35.07%, which was up 67300.0% from 32.65% recorded in Q2 2025.
  • Metlife's 5-year EBIT Margin high stood at 35.07% for Q3 2025, and its period low was 16.09% during Q3 2022.
  • Its 5-year average for EBIT Margin is 29.18%, with a median of 29.2% in 2024.
  • In the last 5 years, Metlife's EBIT Margin soared by 174300bps in 2021 and then plummeted by -168500bps in 2022.
  • Over the past 5 years, Metlife's EBIT Margin (Quarter) stood at 29.56% in 2021, then dropped by -3bps to 28.6% in 2022, then fell by -1bps to 28.2% in 2023, then grew by 3bps to 28.96% in 2024, then grew by 21bps to 35.07% in 2025.
  • Its EBIT Margin was 35.07% in Q3 2025, compared to 32.65% in Q2 2025 and 26.31% in Q1 2025.